Schizophrenia Research
Volume 56, Issue 1 , Pages 87-94 , 1 July 2002

The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms

Received 20 January 2001 ,Accepted 10 April 2001.

References 

  1. Arbeitsgemeinschaft für Methodik und Diagnostik in der Psychiatrie (AMDP), 1981. Rev. Aufl. 1995 Manual Zur Dokumentation Psychiatrischer Befunde, fifth ed. Springer, Berlin.
  2. Andreasen NC. The scale for the assessment of negative symptoms (SANS). Iowa City: University Of Iowa; 1983;
  3. Angst J, Stassen HH, Woggon B. Effect of neuroleptics on positive and negative symptoms and the deficit state. Psychopharmacology (Berlin). 1989;99(Suppl.):41–46
  4. Bleuler M. Dementia Praecox or the Group of Schizophrenias. New York: International University Press; 1950; (Trans. J. Zint)
  5. Bobon D, Woggon B. The AMDP system in clinical psychopharmacology. Br. J. Psychiatry. 1986;148:467–468
  6. Carpenter WT, Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am. J. Psychiatry. 1988;145(5):578–583
  7. Degkwitz R, Helmchen H, Kockott G, Mombour W. Diagnosenschlüssel und Glossar Psychiatrischer Krankheiten. 5. Aufl. Korr. nach der 9. Rev. der ICD. Deutsche Ausgabe der Internationalen Klassifikation der Krankheiten der WHO. ICD 9. Rev. Kap V. Berlin: Springer; 1980;
  8. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry. 1976;33(6):766–771
  9. Faehndrich E, Helmchen H, Hippius H. The history of the AMDP-system. Mod. Probl. Pharmacopsychiatry. 1983;20:1–9
  10. Fenton WS, McGlashan TH. Testing systems for assessment of negative symptoms in schizophrenia. Arch. Gen. Psychiatry. 1989;49(3):236–237 (see comments)
  11. Fenton, W.S., 1997. Course and outcome in schizophrenia, Curr Opin Psychiatry 10 (1), 40–44.
  12. Gerbaldo H, Philipp M. The deficit syndrome in schizophrenic and nonschizophrenic patients: preliminary studies. Psychopathology. 1995;28(1):55–63
  13. Goldberg JF, Harrow M, Grossman LS. Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am. J. Psychiatry. 1995;152:379–385
  14. Grossman LS, Harrow M, Goldberg JF, Fichtner CG. Outcome of schizoaffective disorder at two long-term follow-ups: comparisons with outcome of schizophrenia and affective disorders. Am. J. Psychiatry. 1991;148(10):1359–1365
  15. Johnstone EC, Frith CD, Crow TJ, Owens DG, Done DJ, Baldwin EJ, et al. The northwick park functional psychosis study: diagnosis and outcome. Psychol. Med. 1992;22(2):331–346
  16. Kay, S.R., Opler, L.A., Fiszbein, A., 1987. Positive and negative syndrome scale (PANNS). Rating Manual. Social and behavioral documents. San Rafael.
  17. Kirkpatrick B, Buchanan RW, Mckenney PD, Alphs LD, Carpenter WT. The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res. 1989;30(2):119–123
  18. Kraepelin E. Dementia Praecox. Edinburgh: E.S. Liningstone; 1919; (Trans. R. M. Barclay)
  19. Krawiecka M, Goldberg D, Vaughan M. A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr. Scand. 1977;55(4):299–308
  20. Kulhara P, Chadda R. A study of negative symptoms in schizophrenia and depression. Compr. Psychiatry. 1987;28(3):229–235
  21. Marneros A, Deister A, Rohde A. Affektive, schizoaffektive und schizophrene Psychosen. Eine vergleichende Lanzeitstudie. Berlin: Springer; 1991;
  22. Mason P, Harrison G, Glazebrook C, Medley I, Croudace T. The course of schizophrenia over 13 years. A report from the international study on schizophrenia (Isos) coordinated by The World Health Organization. Br. J. Psychiatry. 1996;169(5):580–586
  23. Mason, P., Harrison, G., Croudace, T., Glazebrook, C., Medley, I., 1997. The predictive validity of a diagnosis of schizophrenia. A report from the International Study of Schizophrenia (ISoS) coordinated by the World Health Organization and the Department of Psychiatry, University of Nottingham. Br J Psychiatry 170, 321–7.
  24. Mayerhoff DI, Loebel AD, Alvir JM, Szymanski SR, Geisler SH, Borenstein M, et al. The deficit state in first-episode schizophrenia. Am. J. Psychiatry. 1994;151(10):1417–1422
  25. McGlashan TH. A selective review of recent North American long-term followup studies of schizophrenia. Schizophr. Bull. 1988;14(4):515–542
  26. Möller HJ. The negative component in schizophrenia. Acta Psychiatr. Scand. 1995;388(Suppl.):11–14
  27. Möller HJ, Schmid Bode W, Cording Tommel C, Wittchen HU, Zaudig M, von Zerssen D. Psychopathological and social outcome in schizophrenia versus affective/schizoaffective psychoses and prediction of poor outcome in schizophrenia. Results from a 5–8 Year follow-up. Acta Psychiatr. Scand. 1988;77:379–389
  28. Möller HJ, Hohe Schramm M, Cording Tommel C, Wittchen HU, Zaudig M, von Zerssen D. The classification of functional psychoses and its implications for prognosis. Br. J. Psychiatry. 1989;154:467–472
  29. National institute of mental health, 1976. CGI. Clinical Global Impressions. In: Guy, W., Bonato, R.R. (Eds.), Manual for the EDCEU Assessment Battery, second ed., vol. 12. Chevy Chase, Maryland, pp. 1–6
  30. Pietzcker A, Gebhardt R, Strauss A, Stockel M, Langer C, Freudenthal K. The syndrome scales in the AMDP-system. Mod. Probl. Pharmacopsychiatry. 1983;20:88–99
  31. Sheperd M. A Study of the Major Psychoses in an English Country. London: Chapman and Hall; 1957;
  32. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr. Scand. 1970;(Suppl. 212):11–19
  33. Tsuang MT, Wollson RF, Fleming JA. Long-term outcome of major psychoses, I: schizophrenia and affective disorders compared with psychiatrically symptom-free surgical conditions. Arch. Gen. Psychiatry. 1979;39:1295–1301

PII: S0920-9964(01)00252-3

doi: 10.1016/S0920-9964(01)00252-3

Schizophrenia Research
Volume 56, Issue 1 , Pages 87-94 , 1 July 2002

Article Tools